The myc family of oncogenes contains coding sequences that have been preserved in different species for over 400 million years. This conservation (which implies functional selection) is broadly represented throughout the C-terminal portion of the human c-myc protein but is largely restricted to three clusters of amino acid sequences in the N-terminal region.
We have examined the role that the latter three regions of the c-myc protein might play in the transforming function of the c-myc gene. Several mutations, deletions and frameshifts, were introduced into the c-myc gene, and these mutant genes were tested for their ability to collaborate with the EJ-ras oncogene to transform rat embryo fibroblasts. Complete elimination of the first two N-terminal conserved segments abolished transforming activity. In contrast, genes altered in a portion of the second or the entire third conserved segment retained their transforming activity. Thus, the latter two segments are not required for the transformation process, suggesting that they serve another function related only to the normal expression of the c-myc gene.
Three members of the myc gene family have been implicated in human malignancy. c-myc is associated with the development of a variety of tumor types in several species, including humans (1) (2) (3) , while N-myc (4, 5) and L-myc (6) have been implicated in the development of malignancy in human cells of neural crest origin. The complete sequences of the human c-and N-myc genes (7) (8) (9) (10) indicate three patches of conserved amino acid sequence in the second exon, each approximately 20 amino acids long, separated from one another by regions of either low or no sequence homology (refs. 9 and 10; Table 1 and Fig. 2 ). These three regions are also conserved between c-myc genes of mouse, chicken, and fish (11) (12) (13) , which diverged over 400 million years ago. The third exon, possibly required for the DNA binding activity of the c-myc protein (14, 15) , is extensively conserved between human, chicken, and fish c-myc and human N-myc (7) (8) (9) (10) (11) (12) (13) .
While the function of the c-myc gene is not known, its transforming properties (16) , its inducibility by growth factors (17) , and its nuclear localization (18) (19) (20) suggest that it might be a nuclear mediator of the action of growth factors. Thus the c-myc protein might be a transducing molecule, receiving a signal and consequently carrying out an action. If the conserved segments of the c-myc protein are to be fitted to such a model, separate functions might be segregated in different conserved portions of the protein and thus be uncoupled from one another. Guided by the example of a transformation-competent c-myc gene with an extensive mutation in a conserved region of the second exon (21) 
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did not introduce undesirable mutations, the Sma I-Sst I fragments of the three frameshift mutants were sequenced to completion in both orientations. No mutations other than the ones specifically introduced were identified.
The mutated Sma I-Sst I c-myc fragments from the M13 vector were inserted into the pSV7Humyc plasmid. This plasmid, which has a simian virus 40 enhancer and early region promoter driving the second and third exons of human c-myc, has been described previously (21) .
In one of the generated deletion mutants (Dhccl, described in Results), a Sma I site was fortuitously created within the second exon by the oligonucleotide-directed mutagenesis. This site was used to insert a truncated c-myc second exon into the pSV7Humyc expression vector. An in-frame ATG codon corresponding to amino acid 101 presumably allowed for initiation of translation, thus giving rise to a c-myc protein (Table 2) we calculated the percent transforming efficiency of each mutant in relation to the wild-type gene (Fig. 2) . Mutants D100, Dcncl, Dcnc2, FScncl, and FScnc2 were virtually nonfunctional in the transformation assay. All these mutants involved the first or second conserved regions between c-myc and N-myc. In contrast Dcnc3, the deletion mutant of the third conserved region between human c-myc and N-myc, had the highest transforming activity of all mutants (32% of wild type). Mutants Dhccl and Dhcc2, bearing deletions of regions conserved between human and chicken c-myc, but not N-myc, had transforming activities that were 4% and 16% of the wild type, respectively. Finally, the frameshift mutant of a nonconserved sequence, FSnocl, had 15% of the wild-type transforming efficiency. The results are shown in comparison to our published studies of the transforming activity of the mutated c-myc gene of the human Burkitt lymphoma cell line Ly65 (21) .
DISCUSSION
It is difficult to draw conclusions regarding mutations that eliminate transforming activity of the c-myc protein. Loss of function could come about for a variety of reasons unrelated to a requirement for a specific sequence: for example, the steric fit of the regions juxtaposed by a deletion or substituted by a pair of frameshift mutations. Thus the loss of transforming activity by mutations in the first two of the three N-terminal conserved segments does not prove that these segments are required for transforming activity. For example, mutant Dcnc2, which has a deletion of the second conserved region between human c-myc and N-myc, has lost transforming activity. On the other hand, the translocated c-myc gene derived from the Burkitt lymphoma cell line Ly65 has a frameshift mutation in a portion of the same conserved segment yet retains transforming activity. This discrepancy may relate to different long-range effects of the mutations on the protein tertiary structure.
Retention of activity in the face of amino acid loss or substitution has significance. When a significant mutation, deletion, or dramatic alteration of primary amino acid sequence does not lead to loss of function, one can argue that the mutated region does not mediate this function. Mutations of nonconserved regions or regions conserved between c-myc genes of different species, but not between c-and N-myc, generally retained transforming activity, confirming their tolerance of evolutionary drift. However, the deletion mutant of the third conserved region between c-myc and N-myc also retained transforming activity, suggesting that it does not directly contribute to the transformation process.
The fact that regions in the N-terminal half of the c-myc protein are conserved in evolution but not required for transformation offers a hint as to how function might be distributed through the structure of the c-myc protein. If c-myc is involved in cell division, it is reasonable to imagine that it acts in concert with other elements that modulate its function. If it is a regulated molecule, its N-terminal exon, for example, might encode a primarily regulatory region. Disturbing such a region might perturb the regulation of c-myc, but not necessarily its subsequent function, which could be more closely related to its action in transformation. Our experiments suggest such a division of function.
